rss
J Clin Pathol 2002;55:399
  • Letters to JCP

Vaccination to prevent varicella and shingles

  1. S J Katona1
  1. 1Department of Immunology, Level 7, Derriford Hospital, Plymouth PL6 8DH, UK; katonas@doctors.org.uk

      In a recent review in this journal, J Breuer1 discussed the use of the Oka live varicella vaccination currently not licensed but obtainable on a named patient basis in the UK, particularly for children with leukaemia or solid organ transplants.2 In the discussion on the universal vaccination strategy in the USA the incidence of serious adverse events was detailed.1

      It should be stressed to clinicians that routine immunisation of all healthy children carries the potential risk that unrecognised immunocompromised children could inadvertently be vaccinated. It is worth bringing attention to the case of a child whose AIDS defining illness was disseminated vaccine strain varicella,3 and a child with severe combined immunodeficiency who developed hepatitis as a result of vaccination with this strain.4

      The child with HIV was vaccinated at a time when his CD4 count was only …

      Latest from JCP Education

      Latest from JCP Education

      Register for free content


      Free sample
      This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
      View free sample issue >>

      Free archive
      The full back archive is now available for JCP. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    • Latest Pathology jobs

      Latest Pathology jobs